Insider · CIK 0001198321

CHAMPSI FARAH

Reports to the SEC for 24 companies · SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001198321

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-01-26	Population Health Investment Co., Inc.Class B Ordinary SharesJ Other	Director	JOther	+43.1K sh	$250.00	+$10.8M	43,125
2017-10-03	Kite Pharma, Inc.Director Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,810 sh	$88.79	−$782K	0
2017-10-03	Kite Pharma, Inc.U Disposition from Tender	Director	UDisposition from Tender	−61.5K sh	$180.00	−$11.1M	1,807
2017-10-03	Kite Pharma, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−1,807 sh	—	—	0
2017-10-03	Kite Pharma, Inc.Director Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−50K sh	$178.65	−$8.93M	0
2017-10-03	Kite Pharma, Inc.Director Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	$120.77	−$1.21M	0
2017-10-03	Kite Pharma, Inc.Director Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,000 sh	$129.13	−$904K	0
2017-09-29	Kite Pharma, Inc.G Gift	Director	GGift	−2,800 sh	—	—	63,274
2017-06-20	Kite Pharma, Inc.A Award	Director	AAward	+2,410 sh	—	—	66,074
2017-06-20	Kite Pharma, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+8,810 sh	—	—	8,810
2017-06-16	Kite Pharma, Inc.S Sale	Director	SSale	−5,450 sh	$88.11	−$480K	0
2017-06-14	Kite Pharma, Inc.S Sale	Director	SSale	−15K sh	$90.40	−$1.36M	63,664
2017-04-28	Kite Pharma, Inc.S Sale	Director	SSale	−2,617 sh	$82.59	−$216K	4,962
2017-04-27	Kite Pharma, Inc.S Sale	Director	SSale	−16.6K sh	$82.77	−$1.37M	7,579
2017-04-26	Kite Pharma, Inc.S Sale	Director	SSale	−51.1K sh	$82.72	−$4.23M	24,330
2017-04-26	Kite Pharma, Inc.S Sale	Director	SSale	−200 sh	$83.06	−$16.6K	24,130
2017-04-25	Kite Pharma, Inc.S Sale	Director	SSale	−31.5K sh	$82.56	−$2.6M	90,758
2017-04-25	Kite Pharma, Inc.S Sale	Director	SSale	−15.3K sh	$83.29	−$1.28M	75,442
2017-04-24	Kite Pharma, Inc.S Sale	Director	SSale	−25.8K sh	$82.34	−$2.13M	122,225
2017-04-17	Kite Pharma, Inc.S Sale	Director	SSale	−100 sh	$83.06	−$8,306	148,043
2017-04-17	Kite Pharma, Inc.S Sale	Director	SSale	−43K sh	$82.48	−$3.55M	148,143
2017-04-13	Kite Pharma, Inc.S Sale	Director	SSale	−72.3K sh	$82.39	−$5.95M	191,144
2016-06-01	Kite Pharma, Inc.A Award	Director	AAward	+1,950 sh	—	—	21,616
2016-06-01	Kite Pharma, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+7,000 sh	—	—	7,000
2015-06-30	Kite Pharma, Inc.S Sale	Director	SSale	−113K sh	$62.14	−$7.02M	2,121,214
2015-06-30	Kite Pharma, Inc.S Sale	Director	SSale	−192K sh	$61.22	−$11.7M	2,234,261
2015-06-30	Kite Pharma, Inc.S Sale	Director	SSale	−359K sh	$63.01	−$22.6M	1,762,457
2015-06-30	Kite Pharma, Inc.S Sale	Director	SSale	−500 sh	$63.82	−$31.9K	1,761,957
2015-06-09	Kite Pharma, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2013-10-23	CHIMERIX INCS Sale	Director	SSale	−447K sh	$15.51	−$6.94M	1,714,330
2013-05-28	PORTOLA PHARMACEUTICALS INCSeries B Preferred StockC Conversion	Director	CConversion	−629K sh	—	—	0
2013-05-28	PORTOLA PHARMACEUTICALS INCC Conversion	Director	CConversion	+75K sh	—	—	74,962
2013-05-28	PORTOLA PHARMACEUTICALS INCC Conversion	Director	CConversion	+1.12M sh	—	—	1,116,214
2013-05-28	PORTOLA PHARMACEUTICALS INCC Conversion	Director	CConversion	+27.5K sh	—	—	27,507
2013-05-28	PORTOLA PHARMACEUTICALS INCSeries B Preferred StockC Conversion	Director	CConversion	−42.3K sh	—	—	0
2013-05-28	PORTOLA PHARMACEUTICALS INCSeries B Preferred StockC Conversion	Director	CConversion	−15.5K sh	—	—	0
2013-05-28	PORTOLA PHARMACEUTICALS INCSeries C Preferred StockC Conversion	Director	CConversion	−28.3K sh	—	—	0
2013-05-28	PORTOLA PHARMACEUTICALS INCSeries C Preferred StockC Conversion	Director	CConversion	−421K sh	—	—	0
2013-05-28	PORTOLA PHARMACEUTICALS INCSeries C Preferred StockC Conversion	Director	CConversion	−10.4K sh	—	—	0
2013-05-28	PORTOLA PHARMACEUTICALS INCSeries D Preferred StockC Conversion	Director	CConversion	−4,447 sh	—	—	0
2013-05-28	PORTOLA PHARMACEUTICALS INCSeries D Preferred StockC Conversion	Director	CConversion	−66.2K sh	—	—	0
2013-05-28	PORTOLA PHARMACEUTICALS INCSeries D Preferred StockC Conversion	Director	CConversion	−1,632 sh	—	—	0
2013-04-16	CHIMERIX INCC Conversion	Director	CConversion	+826K sh	—	—	826,474
2013-04-16	CHIMERIX INCC Conversion	Director	CConversion	+551K sh	—	—	2,161,829
2013-04-16	CHIMERIX INCC Conversion	Director	CConversion	+689K sh	—	—	1,515,203
2012-04-16	CHIMERIX INCSeries E Preferred StockC Conversion	Director	CConversion	−2.44M sh	—	—	0
2012-04-16	CHIMERIX INCSeries F Preferred StockC Conversion	Director	CConversion	−1.96M sh	—	—	0
2012-04-16	CHIMERIX INCSeries D Preferred StockC Conversion	Director	CConversion	−2.93M sh	—	—	0
2005-08-08	RENOVIS INCJ Other	No longer a Director	JOther	−482K sh	—	—	665,976
2005-08-08	RENOVIS INCJ Other	No longer a Director	JOther	+2,385 sh	—	—	45,087

Recent filings

Accepted (ET)
Jan 264
CHAMPSI FARAH0000899243-21-003406
SEC(opens sec.gov)
Oct 54
CHAMPSI FARAH0001209191-17-056230
SEC(opens sec.gov)
Jun 224
Kite Pharma, Inc.0001209191-17-041312
SEC(opens sec.gov)
Jun 164
Kite Pharma, Inc.0001209191-17-040610
SEC(opens sec.gov)
May 14
Kite Pharma, Inc.0001209191-17-029021
SEC(opens sec.gov)
Apr 264
Kite Pharma, Inc.0001209191-17-028231
SEC(opens sec.gov)
Apr 174
Kite Pharma, Inc.0001209191-17-027183
SEC(opens sec.gov)

Address

ONE EMBARCADERO CENTER SUITE 3700

SAN FRANCISCO, CA, 94132